Senior Medical Science Liaison

Rare Lipid & Metabolic Disease | UK Field-Based

We are partnering exclusively with a specialist pharmaceutical company building a new UK Medical Affairs capability to support the launch of an innovative therapy within rare lipid and metabolic disease, with future expansion into a broader specialist population.

This is a high-impact field medical role offering the opportunity to be involved at an early stage in a new disease area, helping to shape medical strategy, stakeholder engagement and patient pathways from the ground up.

The role can be appointed at MSL or Senior MSL level, depending on experience.

As a field-based Medical Science Liaison, you will act as a trusted scientific partner to healthcare professionals and external experts, driving high-quality, non-promotional scientific exchange across a specialist NHS landscape.

Key responsibilities include:

• Building and maintaining strong, credible relationships with KOLs, specialist clinicians, and academic experts
• Leading scientific exchange on rare lipid and metabolic disease, including disease pathways, clinical evidence and patient management
• Delivering medical education and disease awareness initiatives aligned to the medical strategy
• Capturing and communicating actionable insights to inform medical, evidence-generation and cross-functional planning
• Supporting launch and post-launch activities, including advisory boards, congresses and expert meetings
• Contributing to evidence-generation activities such as registries, real-world evidence, non-interventional studies and investigator-initiated research
• Working closely with Medical Affairs, Market Access and Commercial colleagues to support aligned, compliant decision-making

You will have:

• A life sciences or medical background (e.g. pharmacy, biomedical science, medicine or similar)
• Previous experience in a UK customer-facing Medical Affairs role (MSL, Senior MSL or equivalent)
• Strong understanding of the UK NHS, particularly specialist or tertiary care pathways
• Experience engaging with cardiology, lipid, metabolic, endocrinology or rare disease stakeholders
• Proven ability to communicate complex scientific data clearly, confidently and compliantly
• A proactive, autonomous working style with strong insight-generation capability
• Experience supporting pre-launch or launch activities, rare disease portfolios, or first-in-class therapies would be highly advantageous.

• Opportunity to work on a new disease area and launch asset
• High visibility role within a growing UK Medical Affairs team
• Strong emphasis on science, strategy and impact, not volume
• Scope to influence future team growth and ways of working
• Competitive salary and benefits package

For more information please contact Julia Day on or